BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong XY, Lang TQ, Yin Q, Zhang PC, Li YP. Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer. Acta Pharmacol Sin 2017;38:1655-62. [PMID: 28713159 DOI: 10.1038/aps.2017.74] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Niveria K, Yadav M, Dangi K, Verma AK. Overcoming challenges to enable targeting of metastatic breast cancer tumour microenvironment with nano-therapeutics: Current status and future perspectives. OpenNano 2022;8:100083. [DOI: 10.1016/j.onano.2022.100083] [Reference Citation Analysis]
2 Renault-Mahieux M, Mignet N, Seguin J, Alhareth K, Paul M, Andrieux K. Co-encapsulation of flavonoids with anti-cancer drugs: a challenge ahead. Int J Pharm 2022;:121942. [PMID: 35728717 DOI: 10.1016/j.ijpharm.2022.121942] [Reference Citation Analysis]
3 Shete MB, Deshpande AS, Shende P. Silybin-based herbal nanocarriers: an advancement in anticancer therapy. Materials Technology. [DOI: 10.1080/10667857.2022.2081286] [Reference Citation Analysis]
4 Yadav AS, Kundu IG, Radharani N, Mishra B, Kundu GC. pH-responsive nanomedicine for breast cancer targeting. Targeted Nanomedicine for Breast Cancer Therapy 2022. [DOI: 10.1016/b978-0-12-824476-0.00019-x] [Reference Citation Analysis]
5 Zhu R, Lang T, Yin Q, Li Y. Nano drug delivery systems improve metastatic breast cancer therapy. Medical Review 2021;1:244-274. [DOI: 10.1515/mr-2021-0011] [Reference Citation Analysis]
6 Hashemi M, Afsharzadeh M, Babaei M, Ebrahimian M, Abnous K, Ramezani M. Enhanced anticancer efficacy of docetaxel through galbanic acid encapsulated into PLA-PEG nanoparticles in treatment of colon cancer, in vitro and in vivo study. Journal of Bioactive and Compatible Polymers 2021;36:520-30. [DOI: 10.1177/08839115211053922] [Reference Citation Analysis]
7 Gu P, Sun M, Li L, Yang Y, Jiang Z, Ge Y, Wang W, Mu W, Wang H. Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells. Front Cell Dev Biol 2021;9:657158. [PMID: 34249913 DOI: 10.3389/fcell.2021.657158] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Zhang BB, Chen XJ, Fan XD, Zhu JJ, Wei YH, Zheng HS, Zheng HY, Wang BH, Piao JG, Li FZ. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells. Acta Pharmacol Sin 2021;42:832-42. [PMID: 33824461 DOI: 10.1038/s41401-021-00648-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
9 Gote V, Nookala AR, Bolla PK, Pal D. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int J Mol Sci 2021;22:4673. [PMID: 33925129 DOI: 10.3390/ijms22094673] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 22.0] [Reference Citation Analysis]
10 Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian S. Nano-soldiers Ameliorate Silibinin Delivery: A Review Study. Curr Drug Deliv 2020;17:15-22. [PMID: 31721702 DOI: 10.2174/1567201816666191112113031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
11 Jha SK, Chung JY, Pangeni R, Choi HS, Subedi L, Kweon S, Choi JU, Byun Y, Kim Y, Park JW. Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling. Journal of Controlled Release 2020;328:368-94. [DOI: 10.1016/j.jconrel.2020.08.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Tuli HS, Mittal S, Aggarwal D, Parashar G, Parashar NC, Upadhyay SK, Barwal TS, Jain A, Kaur G, Savla R, Sak K, Kumar M, Varol M, Iqubal A, Sharma AK. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol 2021;73:196-218. [PMID: 33130037 DOI: 10.1016/j.semcancer.2020.09.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
13 Liu Y, Xie X, Hou X, Shen J, Shi J, Chen H, He Y, Wang Z, Feng N. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis. J Nanobiotechnology 2020;18:83. [PMID: 32473632 DOI: 10.1186/s12951-020-00638-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
14 Lu Y, Gao X, Cao M, Wu B, Su L, Chen P, Miao J, Wang S, Xia R, Qian J. Interface crosslinked mPEG-b-PAGE-b-PCL triblock copolymer micelles with high stability for anticancer drug delivery. Colloids Surf B Biointerfaces 2020;189:110830. [PMID: 32045844 DOI: 10.1016/j.colsurfb.2020.110830] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
15 Rostamizadeh K, Torchilin VP. Polymeric nanomicelles as versatile tool for multidrug delivery in chemotherapy. Nanopharmaceuticals 2020. [DOI: 10.1016/b978-0-12-817778-5.00003-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Eftekhari RB, Maghsoudnia N, Samimi S, Zamzami A, Dorkoosh FA. Co-Delivery Nanosystems for Cancer Treatment: A Review. PNT 2019;7:90-112. [DOI: 10.2174/2211738507666190321112237] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
17 Lang T, Yin Q, Li Y. Progress of Cell-Derived Biomimetic Drug Delivery Systems for Cancer Therapy. Adv Therap 2018;1:1800053. [DOI: 10.1002/adtp.201800053] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]